Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tudor Investment Corporation, commonly known as Tudor Capital, is a leading multi-strategy hedge fund and asset management firm founded in 1980 by Paul Tudor Jones. While the firm is a diversified global investment manager, it maintains a significant presence in the healthcare and life sciences sectors through dedicated investment teams focusing on biotechnology, pharmaceuticals, and medical technology. Tudor Capital is recognized for its macro trading expertise but has expanded to include private equity and venture capital investments in emerging healthcare companies. The firm operates globally with a focus on identifying high-growth opportunities in clinical-stage biotech and established pharmaceutical entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tudor Capital.